Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $1 | $1 | $0 |
| Gross Profit | -$0 | -$1 | -$1 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $8 | $8 | $8 | $11 |
| G&A Expenses | $3 | $6 | $6 | $7 |
| SG&A Expenses | $3 | $6 | $6 | $7 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11 | $13 | $14 | $19 |
| Operating Income | -$12 | -$13 | -$14 | -$19 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$11 | -$13 | -$14 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$13 | -$14 | -$18 |
| % Margin | – | – | – | – |
| EPS | -0.09 | -0.1 | -0.11 | -0.15 |
| % Growth | 10.1% | 9.1% | 26.7% | – |
| EPS Diluted | -0.09 | -0.1 | -0.11 | -0.15 |
| Weighted Avg Shares Out | 127 | 127 | 126 | 126 |
| Weighted Avg Shares Out Dil | 127 | 127 | 126 | 126 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$11 | -$12 | -$13 | -$18 |
| % Margin | – | – | – | – |